Preclinical efficacy and safety of novel SNAT against SARS-CoV-2 using a hamster model

To address the unprecedented global public health crisis due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we designed and developed a novel antiviral nano-drug, called SNAT (Smart Nano-Enabled Antiviral Therapeutic), comprised of taxoid (Tx)-decorated amino (NH(2))-functionalized...

Descripción completa

Detalles Bibliográficos
Autores principales: Pokhrel, Lok R., Williams, Frank, Cook, Paul P., O’Rourke, Dorcas, Murray, Gina, Akula, Shaw M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017740/
https://www.ncbi.nlm.nih.gov/pubmed/35441321
http://dx.doi.org/10.1007/s13346-022-01166-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017740/
https://www.ncbi.nlm.nih.gov/pubmed/35441321
http://dx.doi.org/10.1007/s13346-022-01166-x

Ejemplares similares